2중 구조 수술용 장갑 시장 : 세계 예측(2026-2032년)

The Double Layered Surgical Gloves Market is projected to grow by USD 2.58 billion at a CAGR of 9.54% by 2032.

Double-Layered Surgical Gloves: Executive Overview

Double-layered surgical gloves are used to add a second barrier between healthcare workers and patients during invasive procedures. Their adoption is shaped by infection-prevention protocols, occupational exposure concerns, operating-room practices, procurement standards, and clinician comfort. Demand is especially relevant in procedures where contact with blood, body fluids, or sharp instruments presents elevated risk.

Barrier Protection Is Reshaping Surgical Glove Practice

Healthcare systems are placing greater emphasis on layered protection, standardized operating-room protocols, and traceable quality assurance. Double-gloving policies are increasingly evaluated alongside glove integrity, fit, tactile sensitivity, donning practices, and replacement intervals. At the same time, hospitals are balancing protection with dexterity, heat, hand fatigue, skin health, waste reduction, and the need for consistent supply across surgical specialties.

Artificial Intelligence Strengthens Quality, Training, and Procurement

Artificial intelligence can support this market indirectly by improving demand planning, identifying procurement anomalies, and analyzing incident or compliance records. Computer-vision systems may assist manufacturing quality checks for visible defects, while analytics can help hospitals compare perforation events, procedure types, glove sizes, and protocol adherence. These applications require validated data, human oversight, privacy safeguards, and clear accountability because clinical decisions should not rely on unverified automated outputs.

Regional Insights: Regulation, Capacity, and Clinical Practice Differ

North America emphasizes occupational safety, hospital protocols, and product consistency, while Europe combines infection prevention with stringent conformity, sustainability, and chemical-management expectations. Asia-Pacific includes diverse healthcare systems, manufacturing capabilities, and procurement conditions, creating varied adoption patterns. Latin America is influenced by public-sector purchasing, import conditions, and uneven hospital resources. The Middle East is shaped by specialized-care expansion, centralized procurement, and international clinical standards. Africa faces infrastructure and supply-continuity constraints, alongside growing attention to infection prevention and healthcare-worker protection.

Group Insights: Blocs Influence Standards and Supply Resilience

ASEAN markets reflect varied regulatory maturity and cross-border supply relationships, making harmonized procurement and training valuable. BRICS members combine major healthcare populations with differing domestic manufacturing and public-purchasing systems. The European Union places strong emphasis on regulatory conformity, worker protection, and environmental considerations. G7 countries generally have mature surgical infrastructure and formal occupational-safety programs. GCC states often use centralized or coordinated purchasing and invest in advanced clinical facilities. NATO members may prioritize resilient medical supply chains, interoperability, and preparedness alongside routine surgical demand.

Country Insights: Local Protocols Shape Adoption

Australia and Canada commonly pair strong hospital governance with established infection-prevention practices. Brazil and Mexico must account for public procurement, regional disparities, and local supply continuity. China and India combine extensive healthcare demand with evolving domestic production and varied institutional standards. France, Germany, Italy, Spain, and the United Kingdom emphasize regulated clinical environments, worker protection, and procedure-specific protocols. Japan and South Korea are associated with advanced healthcare infrastructure and attention to product quality and usability. Russia's market conditions are influenced by domestic availability, procurement structures, and healthcare-system requirements. The United States places substantial focus on occupational exposure prevention, hospital compliance, and product performance.

Actions for Leaders: Convert Barrier Protection into Measurable Practice

Leaders should align double-gloving policies with procedure risk, surgical specialty, and local clinical guidance rather than applying a uniform rule without evaluation. Establish glove-selection criteria covering barrier integrity, sizing, tactile performance, skin compatibility, packaging, and documentation. Track compliance, glove changes, perforation events, staff feedback, and waste by procedure type. Diversify qualified sources, validate substitutions before use, and maintain contingency inventories for critical settings. Training should address correct sizing, donning, removal, hand hygiene, and reporting of defects or exposure incidents. Sustainability programs should assess material use, packaging, disposal, and infection-control trade-offs together.

Methodology: Evidence-Based Assessment of Surgical Glove Adoption

This executive summary uses a structured review of the defined double-layered surgical gloves market, organized around clinical use, infection prevention, occupational safety, regulation, procurement, technology, and supply-chain conditions. Regional, group, and country comparisons are qualitative and reflect differences in healthcare infrastructure, policy environments, manufacturing, and purchasing practices. No market estimates, market shares, forecasts, or company-level claims are included. Findings should be validated against current national regulations, hospital guidelines, peer-reviewed evidence, procurement records, and post-market quality data before operational decisions are made.

Conclusion: Stronger Protection Requires Integrated Implementation

Double-layered surgical gloves are most effective when treated as part of a broader risk-control system rather than as a standalone product choice. Successful implementation depends on evidence-based protocols, dependable quality, appropriate sizing, staff training, continuous monitoring, and resilient procurement. Regional and national differences require localized execution, while emerging analytics and artificial intelligence can improve oversight when deployed with validation and clinical governance.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Double Layered Surgical Gloves Market, by Material

• 7.1. Introduction
• 7.2. Latex
• 7.3. Neoprene
• 7.4. Nitrile
• 7.5. Polyisoprene
• 7.6. Vinyl

8. Double Layered Surgical Gloves Market, by Sterility

• 8.1. Introduction
• 8.2. Non Sterile
• 8.3. Sterile

9. Double Layered Surgical Gloves Market, by Thickness

• 9.1. Introduction
• 9.2. 6.0 To 6.5 Mil
• 9.3. 6.6 To 7.0 Mil
• 9.4. Above 7.0 Mil

10. Double Layered Surgical Gloves Market, by Application

• 10.1. Introduction
• 10.2. Cardiovascular Surgery
• 10.3. General Surgery
• 10.4. Neurosurgery
• 10.5. Orthopedic Surgery

11. Double Layered Surgical Gloves Market, by End User

• 11.1. Introduction
• 11.2. Ambulatory Surgery Centers
• 11.3. Clinics
• 11.4. Hospitals
• 11.5. Research Laboratories

12. Double Layered Surgical Gloves Market, by Sales Channel

• 12.1. Introduction
• 12.2. Offline
• 12.3. Online

13. Double Layered Surgical Gloves Market, by Region

• 13.1. Introduction
• 13.2. Asia-Pacific
• 13.3. North America
• 13.4. Latin America
• 13.5. Europe
• 13.6. Middle East
• 13.7. Africa

14. Double Layered Surgical Gloves Market, by Group

• 14.1. Introduction
• 14.2. ASEAN
• 14.3. GCC
• 14.4. European Union
• 14.5. BRICS
• 14.6. G7
• 14.7. NATO

15. Double Layered Surgical Gloves Market, by Country

• 15.1. Introduction
• 15.2. United States
• 15.3. Canada
• 15.4. Mexico
• 15.5. Brazil
• 15.6. United Kingdom
• 15.7. Germany
• 15.8. France
• 15.9. Russia
• 15.10. Italy
• 15.11. Spain
• 15.12. China
• 15.13. India
• 15.14. Japan
• 15.15. Australia
• 15.16. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. Market Concentration Analysis, 2025
  • 16.2.1. Concentration Ratio (CR)
  • 16.2.2. Herfindahl Hirschman Index (HHI)
• 16.3. Recent Developments & Impact Analysis, 2025
• 16.4. Product Portfolio Analysis, 2025
• 16.5. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Ansell Limited
• 17.2. B. Braun Melsungen AG
• 17.3. Hartalega Holdings Berhad
• 17.4. Kanam Latex Industries Private Limited
• 17.5. Kossan Rubber Industries Berhad
• 17.6. Maple Leaf Rubber Products Sdn Bhd
• 17.7. Medline Industries LP
• 17.8. MRK Healthcare Private Limited
• 17.9. Nulife Inflexion
• 17.10. Rubberex Corporation (M) Berhad
• 17.11. Semperit AG Holding
• 17.12. Sri Trang Agro-Industry Public Company Limited
• 17.13. Supermax Corporation Berhad
• 17.14. Top Glove Corporation Berhad
• 17.15. YTY Group Holdings Berhad

18. Key Experts